Intermountain ekes out slim profit, weighed down by supply, labor costs
The Salt Lake City-based system, which merged earlier this year with Colorado-based SCL Health, said labor expenses are up 45% from a year ago.
Lawmakers object to latest surprise billing rule, call for changes
House Ways and Means Committee leaders “are severely disappointed to find that the August 2022 final rule violates the No Surprises Act in the same ways as before,” they wrote in a letter to regulators last week.
State AGs urge Apple to protect consumers’ reproductive health data
Apps holding sensitive health data should be required to delete nonessential information and clearly inform consumers what information they share with parties such as law enforcement, the 10 state attorneys general said.
Will healthcare look different in 2023?
How is healthcare is changing for providers as we enter 2023, and what can we do to prepare?
Morgan Health nabs Walmart executive to accelerate strategy around population health
Cheryl Pegus is leaving Walmart’s health division to work as a managing director for JPMorgan’s venture attempting to lower employer health costs.
UnitedHealth-Change deal approval faces appeal from DOJ, states
Antitrust experts said it’s surprising regulators took this long to file an appeal, while UnitedHealth slammed the move as “entirely without merit.”
Epic ensnared in Texas probe of parental access to teen medical records
The state is at the forefront of an intensifying legal battle over the rights of transgender and non-binary children to gender-affirming healthcare.
Mayo Clinic income slumps as expenses climb in Q3
Expenses outpaced revenue growth as the Minnesota-based health system became the latest provider to report a recent drop in operating income.
Lifespan brings on Mass General Brigham executive as new CEO
John Fernandez will assume the role early next year and replace Timothy Babineau, who held the position for more than 10 years.
Healthcare technology companies weigh finance options to stem cash burn as IPO market sags
Healthcare technology companies are delaying initial share sales as public market stocks and valuations plunge across the sector. Where will they turn in the meantime?